By Vijay Kumar Malesu Reviewed by Benedette Cuffari, M.Sc. May 6 2026 Widely used diabetes and obesity drugs show powerful heart-protective effects in high-risk patients, offering new momentum for their role in reducing cardiovascular deaths. Study: The long-term cardiovascular safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in high-risk cardiovascular populations: a systematic review and meta-analysis. Image Credit: Studio Romantic / Shutterstock.com In a recent study